Increasing Productivity and Profitability

SmartScale

Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model

Jesse McCool, Ph.D.

GBI Biomanufacturing

Organ-on-a-Chip

Why Multi-Organ Chips Are a Manufacturing and Standardization Challenge

Pharma's Almanac

CGT Release

Release Testing as a Cell and Gene Therapy Manufacturing Bottleneck

Pharma's Almanac

LNP Analytics

Beyond Particle Size: Building a Complete Analytical Strategy for LNPs

Pharma's Almanac

API Oversight

Can Regulatory Reliance Make Global API Oversight More Efficient?

Pharma's Almanac

NAMs

The EMA Builds a Regulatory Safe Harbor for New Approach Methodologies

Pharma's Almanac

Oncolytic Viruses

Turning Oncolytic Viruses into Manufacturable Cancer Therapies

Luisa Amoedo Otero

Recipharm Advanced Bio

Drug Shortage

What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage

David Alvaro, Ph.D.

Pharma's Almanac

Biosimilars

The Global Division of Labor Behind the Coming Oncology Biosimilar Wave

Pharma's Almanac

CCS and CMC

Packaging Returns to the Center of CMC Strategy

Pharma's Almanac

iPSCs

For iPSC Therapies, Manufacturing Consistency May Mean Preserving Function

Pharma's Almanac